Meeder Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Meeder Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-161	Closed	-$1K	–	2563
2021 Q4	$1K	Buy	+161	New	+$3.03K	﹤0.01%	1065
2021 Q2	–	Sell	-2,551	Closed	-$117K	–	2709
2021 Q1	$117K	Buy	+2,551	New	+$119K	0.01%	881
2020 Q4	–	Sell	-1,152	Closed	-$58K	–	2297
2020 Q3	$58K	Sell	1,152 -284	-20%	-$13.9K	﹤0.01%	927
2020 Q2	$86K	Buy	1,436 +804	+127%	+$43K	0.01%	793
2020 Q1	$26K	Sell	632 -1,630	-72%	-$90.5K	﹤0.01%	1154
2019 Q4	$141K	Buy	2,262 +2,108	+1,369%	+$100K	0.01%	702
2019 Q3	$5K	Buy	+154	New	+$4.56K	﹤0.01%	1785
2018 Q3	–	Sell	-35	Closed	-$1.38K	–	1721
2018 Q2	$1.38K	Sell	35 -3	-8%	-$88	﹤0.01%	1456
2018 Q1	$1K	Buy	+38	New	+$962	﹤0.01%	1495

Other funds holding DCPH

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Meeder Asset Management's DCPH Position: Q1 2022 in Review

Meeder Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2022, closing a stake of 161 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in DCPH in Q1 2018 and held it in 9 quarters. The position peaked at $141K in Q4 2019. 123 funds tracked by Wall St. Rank hold DCPH as of Q1 2022.

Meeder Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Meeder Asset Management sold 161 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $1K.
Meeder Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
Meeder Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $141K in Q4 2019.
123 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Meeder Asset Management's 13F filing for Q1 2022, filed 10 May 2022.